Showing the single result

  • Afatinib 20 mg

    Afatinib 20 mg

    0 out of 5
    $98

    Afatinib 20 mg is a targeted therapy used in the treatment of non-small cell lung cancer (NSCLC). It works as a tyrosine kinase inhibitor (TKI), blocking the activity of abnormal EGFR proteins that drive cancer cell growth.

    Select optionsDone This product has multiple variants. The options may be chosen on the product page

End of content

End of content